**Abstract**

Neuroligins (Nlgns) are postsynaptic adherent molecules consisting of five family members (Nlgn1, 2, 3, 4X and 4Y). A number of genetic studies showed that the mutations of *Nlgn2*, *3* and *4* have been associated with neuropsychiatric disorders including autism spectrum disorder (ASD). However, only few genetic and functional analyses have been reported in *Nlgn1.*

In this study, we introduced whole-exome sequencing technique to find mutations in ASD siblings and identified a novel mutation predicted as damaging by *in silico* analysis. To uncover its functional significance, we performed comprehensive analyses both *in vitro* and *in vivo*.

We introduced this NLGN1 mutation into the mouse primary hippocampal neurons. The NLGN1 mutation altered not only subcellular localization from cytoplasm to endoplasmic reticulum (ER) but also dendritic spine induction.

To address how this mutation affects behavioral phenotypes., we generated knock-in mice with *Nlgn1* mutation by direct injection of CRISPR/Cas9 RNA with guide RNA. In a series of behavioral tests, we found several autistic traits, such as impaired social communication, in addition to hippocampal dependent spatial memory deficit. Furthermore, our biochemical studies revealed that Nlgn1 protein was significantly decreased in the forebrain of mutant mice (both whole lysate and synaptosomal fraction). These results suggest that this novel *Nlgn1* mutation is involved in ASD traits in a haploinsufficient manner and reinforce the significant association between mutations in Nlgns and neuropsychiatric disorders.
